Inactive Instrument

Guided Therapeutics Inc Stock OTC Bulletin Board

Equities

US40171F1057

Advanced Medical Equipment & Technology

End-of-day quote OTC Bulletin Board
- USD - Intraday chart for Guided Therapeutics Inc
Sales 2022 13K Sales 2023 98K Capitalization 8.31M
Net income 2022 -4M Net income 2023 -3M EV / Sales 2022 1,118 x
Net cash position 2022 50K Net Debt 2023 1.47M EV / Sales 2023 99.7 x
P/E ratio 2022
-1.96 x
P/E ratio 2023
-2.09 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 56.3%
More Fundamentals * Assessed data
Guided Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Guided Therapeutics Announces Completion of Clinical Study for Chinese Regulatory Approval CI
Guided Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Guided Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Guided Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Guided Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Guided Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt CI
Guided Therapeutics, Inc. Announces CEO Changes CI
Guided Therapeutics, Inc. Announces Executive Changes CI
Guided Therapeutics Signs Agreement to Begin Clinical Trial for US FDA Approval CI
Guided Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Guided Therapeutics Provides Update of Significant Progress in Chinese Clinical Study for Marketing Approval of the LuViva Advanced Cervical Scan CI
Guided Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Guided Therapeutics, Inc. Receives Institutional Review Board Approval to Start Clinical Study for FDA Approval of the LuViva® Advanced Cervical Scan CI
Guided Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
More news
Managers TitleAgeSince
Chief Executive Officer 68 92-10-26
Founder 68 92-10-26
Members of the board TitleAgeSince
Director/Board Member 74 06-04-09
Director/Board Member 67 16-11-09
Chief Executive Officer 68 92-10-26
More insiders
Guided Therapeutics, Inc. is a medical technology company. The Company is focused on developing medical devices that have the potential to improve healthcare. The Company’s primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. LuViva is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point of care by scanning the cervix with light, then analyzing the reflected and fluorescent light. LuViva is designed to provide a less invasive and painless alternative to conventional tests for cervical cancer screening and detection. Additionally, LuViva is designed to improve patient well-being not only because it eliminates pain, but also because it is convenient to use and provides rapid results at the point of care.
More about the company